North America Disposable Syringes Market Size, Share & Industry Trends Analysis Report By Application (Therapeutic Injections, and Immunization Injections), By Product, By Country and Growth Forecast, 2023 - 2030

The North America Disposable Syringes Market should witness market growth of 5.7% CAGR during the forecast period (2023-2030).

Disposable syringes are used to draw blood samples from patients. These are also used to boost immunity against weakened strains of viruses. Syringes also employ a piston mechanism for blood collection and medicine delivery. Syringes come in various varieties, each with a unique set of benefits. The increase in surgical operations is driving the market. Needles are used in all procedures to inject liquids and remove bodily secretions.

Anaesthesiology is one of the common procedures to be carried following surgeries. In this, the patient is injected with drugs for pain free surgeries. Other factors driving the market's expansion include the rise in chronic diseases that need disposable syringe systems and the increase in needlestick injuries cases. Rural health care providers had a higher percentage of improper injection procedures, which raises the risk of damages caused by needle sticks in the general population. The market's growth during the projected period is an increase in demand for vaccinations and immunizations, technical developments, and a surge in the adoption of injectable medications.

In the U.S., 37.3 million people (11.3% of the population) had diabetes in June 2022, according to data published by the CDC. In addition, 96 million adults in the U.S., or more than 1 in 3 people, have prediabetes. Prediabetes increases the likelihood of developing type 2 diabetes, cardiovascular disease, and stroke. The sales in North America are expected to grow due to rising diabetes prevalence and expanding government programs for prevention and control.

The US market dominated the North America Disposable Syringes Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $5,220.1 Million by 2030. The Canada market is showcasing a CAGR of 8.1% during (2023-2030). Additionally, The Mexico market should witness a CAGR of 7.2% during (2023-2030).

Based on Application, the market is segmented into Therapeutic Injections, and Immunization Injections. Based on Product, the market is segmented into Safety Syringes (Retractable, and Non-retractable), and Conventional Syringes. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Fresenius SE & Co. KGaA, Terumo Corporation, Novo Nordisk A/S, Baxter International, Inc., B. Braun Melsungen AG, Flextronics International, Ltd., Nipro Corporation, and UltiMed, Inc.

Scope of the Study

By Application

• Therapeutic Injections
• Immunization Injections

By Product

• Safety Syringes
  • Retractable
  • Non-retractable
• Conventional Syringes

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Becton, Dickinson and Company
• Medtronic PLC
• Fresenius SE & Co. KGaA
• Terumo Corporation
• Novo Nordisk A/S
• Baxter International, Inc.
• B.Braun Melsungen AG
• Flextronics International, Ltd.
• Nipro Corporation
• UltiMed, Inc.

Unique Offerings

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free